Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0489 Transporter Info
Gene Name	SLC9A5
Transporter Name	Sodium/hydrogen exchanger 5
Gene ID	6553
UniProt ID	Q14940

Post-Translational Modification of This DT
Overview of SLC9A5 Modification Sites with Functional and Structural Information
Sequence	M L R A A L S L L A L P L A G A A E E P T Q K P E S P G E P P P G L E L F R W Q W H E V E A P Y L V A L W I L V A S L A K I V F H L S R K V T S L V P E S C L L I L L G L V L G G I V L A V A K K A E Y Q L E P G T F F L F L L P P I V L D S G Y F M P S R L F F D N L G A I L T Y A V V G T L W N A F T T G A A L W G L Q Q A G L V A P R V Q A G L L D F L L F G S L I S A V D P V A V L A V F E E V H V N E T L F I I V F G E S L L N D A V T V V L Y K V C N S F V E M G S A N V Q A T D Y L K G V A S L F V V S L G G A A V G L V F A F L L A L T T R F T K R V R I I E P L L V F L L A Y A A Y L T A E M A S L S A I L A V T M C G L G C K K Y V E A N I S H K S R T T V K Y T M K T L A S C A E T V I F M L L G I S A V D S S K W A W D S G L V L G T L I F I L F F R A L G V V L Q T W V L N Q F R L V P L D K I D Q V V M S Y G G L R G A V A F A L V I L L D R T K V P A K D Y F V A T T I V V V F F T V I V Q G L T I K P L V K W L K V K R S E H H K P T L N Q E L H E H T F D H I L A A V E D V V G H H G Y H Y W R D R W E Q F D K K Y L S Q L L M R R S A Y R I R D Q I W D V Y Y R L N I R D A I S F V D Q G G H V L S S T G L T L P S M P S R N S V A E T S V T N L L R E S G S G A C L D L Q V I D T V R S G R D R E D A V M H H L L C G G L Y K P R R R Y K A S C S R H F I S E D A Q E R Q D K E V F Q Q N M K R R L E S F K S T K H N I C F T K S K P R P R K T G R R K K D G V A N A E A T N G K H R G L G F Q D T A A V I L T V E S E E E E E E S D S S E T E K E D D E G I I F V A R A T S E V L Q E G K V S G S L E V C P S P R I I P P S P T C A E K E L P W K S G Q G D L A V Y V S S E T T K I V P V D M Q T G W N Q S I S S L E S L A S P P C N Q A P I L T C L P P H P R G T E E P Q V P L H L P S D P R S S F A F P P S L A K A G R S R S E S S A D L P Q Q Q E L Q P L M G H K D H T H L S P G T A T S H W C I Q F N R G S R L
PTM type	X-N-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A5			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	199
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC9A5 Asparagine 199 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC9A5			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	319
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC9A5 Asparagine 319 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A5			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	656
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC9A5 Cystine 656 has the potential to affect its expression or activity.
Phosphorylation
Serine	12 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A5			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	321
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 321 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC9A5			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	567
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 567 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC9A5			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	575
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 575 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC9A5			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	577
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 577 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC9A5			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	647
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 647 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC9A5			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	702
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 702 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC9A5			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	709
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 709 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC9A5			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	711
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 711 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC9A5			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	712
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 712 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC9A5			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	739
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 739 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC9A5			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	741
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 741 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC9A5			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	747
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Serine 747 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC9A5			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	566
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Threonine 566 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC9A5			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	569
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Threonine 569 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC9A5			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	681
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Threonine 681 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC9A5			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	714
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 Threonine 714 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Increasing the cell surface accumulation and activity of SLC9A5			[11]
Role of PTM	Surface Expression Modulation
Related Enzyme	5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
Experimental Material(s)	NHE5-transfected non-neuronal cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC9A5 have been reported to increase its cell surface accumulation and transport activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SL9A5_HUMAN)
2	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3	Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways. Mol Cell Proteomics. 2012 Dec;11(12):1741-57.
4	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
5	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
6	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
7	CK2 phosphorylation of an acidic Ser/Thr di-isoleucine motif in the Na+/H+ exchanger NHE5 isoform promotes association with beta-arrestin2 and endocytosis. J Biol Chem. 2011 Apr 1;286(13):11456-68.
8	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
9	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
10	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
11	Activation of AMP-activated protein kinase regulates hippocampal neuronal pH by recruiting Na(+)/H(+) exchanger NHE5 to the cell surface. J Biol Chem. 2014 Jul 25;289(30):20879-97.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence